INHIBITORY EFFECT OF A STANDARDIZED HYDROETHANOLIC EXTRACT OF TERMINALIA ARJUNA BARK ON ALPHA-AMYLASE ENZYMEINHIBITORY EFFECT OF A STANDARDIZED HYDROETHANOLIC EXTRACT OF TERMINALIA ARJUNA BARK ON ALPHA-AMYLASE ENZYME
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i4.24019Keywords:
Terminalia arjuna, Acarbose, Diabetes, Enzyme inhibition, Arjunetin, ArjungeninAbstract
 Objective: The present study was initiated to screen the hydroethanolic bark extract for α-amylase inhibitory activity and standardization of the Terminalia arjuna for polyphenolic phytochemicals using high-performance liquid chromatography-photo diode array (HPLC-PDA) method.
Methods: The T. arjuna bark sample was extracted with ethanol: water (70:30 v/v) using Soxhlet extraction. A Dionex P680 HPLC system was used to acquire chromatograms. The screening of extract of T. arjuna bark has performed for in vitro α-amylase inhibitory assay. Each experiment was repeated 3 times. All values were expressed mean ± standard deviation.
Results: The content of arjunetin, arjungenin, gallic acid, ellagic acid, and quercetin was 0.47, 8.22, 2.443, 7.901, and 3.20 mg/g, respectively, in a hydroethanolic extract of T. arjuna. The hydroethanolic extract of T. arjuna bark and acarbose has shown an inhibitory activity with an IC50 value 145.90 and 62.35 μg/mL, respectively.
Conclusion: The hydroethanolic extract T. arjuna bark demonstrates α-amylase inhibitory activity due to a synergistic effect of the phytochemical constituents present in it. This study suggests that one of the mechanisms of this plant for antidiabetic activity is through the inhibition of α-amylase enzyme.
Downloads
References
Kazeem MI, Adamson JO, Ogunwande IA. Modes of inhibition of α-amylase and α-glucosidase by aqueous extract of Morinda lucida Benth Leaf. BioMed Res Inter 2013;527570:6.
Jyothi KS, Hemalatha P, Avanthi A, Challa S. A comparative analysis on the alpha amylase inhibitory potential of six ornamental medicinal plants. J Nat Prod Plant Resour 2013;3:1-6.
Prabu M, Kumuthakalavalli R. Antidiabetic potential of the oyster mushroom Pleurotus florida (mont.) singer. Int J Curr Pharm Res 2017;9:51-4.
Shareef MI, Reddy PJ, Gopinath SM, Dayananda KS, Mandal A, Purushotham KM. In vitro α-amylase inhibitory activity of the leaves of Tinospora cordifolia. Inter J Innovat Res in Sci Eng Tech 2014;3:10091-6.
Dineshkumar B, Mitra A, Manjunatha M. A comparative study of alpha amylase inhibitory activities of common anti-diabetic plants at kharagpur 1 block. Inter J of Green Pharm 2010;4:115-21.
Rupeshkumar M, Kunchu K, Pallab H. Role of herbal plants in the diabetes mellitus therapy: An overview. Int J App Pharm 2014;6:1-3.
Reka P, Thahira B, Seethalakshmi M. Alpha amylase and alpha glucosidase inhibition activity of selected edible seaweeds from south coast area of India. Int J Pharm Pharm Sci 2017;9:64-8.
Chakrabarti R, Singh B, Prakrith VN, Vanchhawng L, Thirumurugan K. Screening of nine herbal plants for in vitro a-amylase inhibition. Asian J Pharm Clin Res 2014;7:84-9.
Biswas M, Kar B, Bhattacharya S, Kumar RB, Ghosh AK, Haldar PK. Antihyperglycemic activity and antioxidant role of Terminalia arjuna leaf in streptozotocin-induced diabetic rats. Pharm Biol 2011;49:335-40.
Dube N, Nimgulkar C, Bharatraj DK. Validation of therapeutic anti-inflammatory potential of arjuna ksheera paka: A traditional ayurvedic formulation of Terminalia arjuna. J Trad Complem Med 2017;7:414-20.
Desai S, Patil B, Kanthe P, Potekar R. Effect of ethanolic extract of Terminalia arjuna on liver functions and histopathology of liver in albino rats fed with hyperlipidemic diet. Int J Pharm Pharm Sci 2015;7:302-6.
Ragavan B, Krishnakumari S. Effect of Terminalia arjuna stem bark extract on the activities of marker enzymes in alloxan induced diabetic rats. Anc Sci Life 2005;25:8-15.
Jaiswal P, Kumar P. Alpha amylase inhibitory activity of different extract of Terminalia arjuna bark. Curr Trends Biotech Pharm 2017;11:253-8.
Saha S, Verma R. Inhibitory potential of traditional herbs on α-amylase activity. Pharm Bio 2012;50:326-31.
Singh DV, Verma RK, Singh SC, Gupta MM. RP-LC determination of oleane derivatives in Terminalia arjuna. J Pharma Biomed Anal 2002;28:447-52.
Lal UR, Tripathi SM, Jachak SM, Bhutani K, Singh I. HPLC analysis and standardization of arjunarishta – An ayurvedic cardioprotective formulation. Sci Pharm 2009;77:605-16.
Shengule SA, Mishra S, Joshi K, Apte K, Patil D, Kale P, et al. Anti-hyperglycemic and anti-hyperlipidaemic effect of Arjunarisht in high-fat fed animals. J Ayurveda Integr Med 2017; DOI.org/10.1016/j.jaim.2017.07.004.
Das P, Panneerselvam T, Prabhu P, Reddy J. Method development and validation of gallic acid and ellagic acid in Argwadharistam. Int J Curr Res 2017;9:61417-20.
Apostolidisa E, Lib L, Leea C, Seeramb NP. In vitro evaluation of phenolic-enriched maple syrup extracts for inhibition of carbohydrate hydrolyzing enzymes relevant to Type 2 diabetes management. J Funct Foods 2011;3:100-6.
Dada FA, Oyeleye SI, Ogunsuyi OB, Olasehinde TA, Adefegha SA, Oboh G, et al. Phenolic constituents and modulatory effects of Raffia palm leaf (Raphia hookeri) extract on carbohydrate hydrolyzing enzymes linked to Type-2 diabetes. J Trad Complem Med 2017;7:494-500.
Singh DV, Verma RK, Gupta MM, Kumar S. Quantitative determination of oleane derivatives in Terminalia arjuna by high performance thin layer chromatography. Phytochem Anal 2002;13:207-10.
Saha A, Pawar VM, Jayaraman S. Characterisation of polyphenols in Terminalia arjuna bark extract. Indian J Pharm Sci 2012;74:339-47.
Sudha P, Zinjarde SS, Bhargava SY, Kumar AR. Potent α-amylase inhibitory activity of Indian ayurvedic medicinal plants. BMC Compl Altern Med 2011;11:5.
Chipiti T, Ibrahim MA, Singh M, Islam MS. In vitro α-amylase and α-glucosidase inhibitory effects and cytotoxic activity of Albizia antunesiana extracts. Pharmacogn Mag 2015;11:S231-6.
Khaliq F, Parveen A, Singh S, Gondal R, Hussain ME, Fahim M. Improvement in myocardial function by Terminalia arjuna in streptozotocin-induced diabetic rats: Possible mechanisms. J Cardiovasc Pharmacol Ther 2013;18:481-9.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
